229.75
전일 마감가:
$233.28
열려 있는:
$230.59
하루 거래량:
668.29K
Relative Volume:
0.84
시가총액:
$22.40B
수익:
$5.94B
순이익/손실:
$785.30M
주가수익비율:
28.96
EPS:
7.9331
순현금흐름:
$972.40M
1주 성능:
-3.83%
1개월 성능:
+5.47%
6개월 성능:
-6.38%
1년 성능:
-6.44%
Steris Plc Stock (STE) Company Profile
명칭
Steris Plc
전화
35312322000
주소
70 SIR JOHN ROGERSON'S QUAY, DUBLIN
Compare STE vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
STE
Steris Plc
|
229.75 | 22.74B | 5.94B | 785.30M | 972.40M | 7.9331 |
|
ABT
Abbott Laboratories
|
110.37 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
331.68 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
90.60 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
51.43 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
90.81 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Steris Plc Stock (STE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-05-29 | 개시 | Jefferies | Hold |
| 2024-10-24 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2023-05-30 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-04-14 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-23 | 다운그레이드 | Needham | Buy → Hold |
| 2022-07-14 | 개시 | Piper Sandler | Overweight |
| 2022-04-07 | 개시 | Wolfe Research | Outperform |
| 2021-05-26 | 업그레이드 | Needham | Hold → Buy |
| 2021-02-04 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-06-09 | 개시 | Needham | Hold |
| 2019-07-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2018-01-03 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-06-05 | 다운그레이드 | Wellington Shields | Gradually Accumulate → Hold |
| 2017-05-03 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2016-11-30 | 개시 | Goldman | Neutral |
| 2016-06-03 | 업그레이드 | Northcoast | Neutral → Buy |
| 2015-06-12 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2013-05-07 | 다운그레이드 | Griffin Securities | Buy → Hold |
| 2013-02-08 | 재확인 | Griffin Securities | Buy |
| 2012-08-03 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2012-02-08 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2011-11-03 | 재확인 | JMP Securities | Mkt Outperform |
| 2011-02-09 | 재확인 | JMP Securities | Mkt Outperform |
| 2010-12-21 | 재확인 | JMP Securities | Mkt Outperform |
| 2010-09-17 | 개시 | JMP Securities | Mkt Outperform |
| 2010-04-07 | 재확인 | CL King | Strong Buy |
| 2010-03-26 | 개시 | CL King | Strong Buy |
| 2010-03-03 | 개시 | Brean Murray | Hold |
모두보기
Steris Plc 주식(STE)의 최신 뉴스
Steris PLC stock underperforms Monday when compared to competitors - MarketWatch
What Is Fueling STERIS (NYSE) Across Surgical Care and Sterilization? - Kalkine Media
Stoneridge Investment Partners LLC Invests $1.03 Million in STERIS plc $STE - marketbeat.com
Steris PLC stock outperforms competitors despite losses on the day - MarketWatch
STE|STERIS plc|Price:235.920|Chg%:-0.680 - TradingKey
STERIS (NYSE:STE) Director Sells $956,795.24 in Stock - marketbeat.com
Steris Insider Sold Shares Worth $956,795, According to a Recent SEC Filing - marketscreener.com
STERIS plc (STE) director logs option exercise, share sale and new awards - Stock Titan
STERIS (STE) director Louis Shapiro granted 1,025 fully vested stock units - Stock Titan
STERIS plc (STE) director Nirav Shah receives new stock options and RSUs - Stock Titan
STERIS plc (STE) director awarded stock options and Career RSUs - Stock Titan
STERIS plc (STE) director Holland receives 1,025 Career Restricted Stock Units - Stock Titan
STERIS (STE) director Cynthia Feldmann receives options and RSU awards - Stock Titan
STERIS plc (STE) director Pierre Boulud receives 1,025 Career RSUs - Stock Titan
STERIS plc (STE) director Esther Alegria receives stock options and RSU awards - Stock Titan
STERIS plc SEC Filing (Aug 12, 2026) - Stock Titan
Steris director Mohsen Sohi sells 4,058 shares worth $956,597.24 - Bitget
STERIS plc (STE) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Jefferies Adjusts Price Target on STERIS to $232 From $225, Maintains Hold Rating - marketscreener.com
Assenagon Asset Management S.A. Has $16.10 Million Stake in STERIS plc $STE - marketbeat.com
STERIS investing $600 million to build formulated chemistries manufacturing and distribution Center of Excellence - Today's Medical Developments
STERIS plc (Ireland) (STE) Stock Forecasts - Yahoo! Finance Canada
STERIS Q1 Earnings Call Highlights - MarketBeat
STERIS (NYSE:STE) Raised to Buy at Wall Street Zen - MarketBeat
Steris plc (0XI8) Q3 2026 Earnings ReportResults, Call & Slides - TipRanks
Did STERIS’ (STE) Record Chemistries Bet and Dividend Hike Just Recast Its Earnings Narrative? - simplywall.st
STERIS (STE) Stock Faces Valuation Scrutiny After Margin Gains And Higher Capex - Sahm
UBS Maintains Steris PLC(STE.US) With Buy Rating, Cuts Target Price to $270 - Moomoo
Piper Sandler Maintains Steris PLC(STE.US) With Buy Rating, Raises Target Price to $275 - 富途牛牛
STERIS plc (Ireland) (STE) Stock forecasts - Yahoo Finance UK
STERIS plc (STE) Announces Shareholder Voting Results and Board Reduction at 2026 Annual General Meeting - GuruFocus
UBS Group Issues Pessimistic Forecast for STERIS (NYSE:STE) Stock Price - MarketBeat
Steris PLC stock outperforms competitors on strong trading day - MarketWatch
STERIS plc 2026: Revenue $1.49B, EPS $2.04— 10-Q Summary - TradingView
STERIS plc (NYSE: STE) lifts Q1 2027 revenue to $1.49B, EPS hits $2.04 - Stock Titan
STE Reiterated by Piper Sandler -- Price Target Raised to $275 - GuruFocus
STERIS (NYSE:STE) Given Overweight Rating at Piper Sandler - MarketBeat
Narrow-Moat Steris' Recurring Revenue and Margin Improvement Create Opportunistic Outlook - Morningstar
UBS Adjusts Price Target on STERIS to $270 From $275, Maintains Buy Rating - marketscreener.com
STERIS plc (STE) Stock News Today - TradingKey
Steris PLC (STE) (Q1 2027) Earnings Call Highlights: Strong Reve - GuruFocus
STERIS plc (Ireland) Stock 12‑Month Price Target Cut to $260.67, Implies 12% Upside - TradingView
Needham Maintains Steris PLC(STE.US) With Hold Rating - Moomoo
Earnings call transcript: STERIS beats Q1 2026 EPS, shares fall on spending plans - Investing.com
Steris Posts Solid Q1 Results Amid Restructuring Plans - The Globe and Mail
NCRR Injecting $600K Into STERIS Facility - Railway Age
Steris plc Appoints Pierre Boulud to the Audit Committee and the Compliance and Technology Committee - marketscreener.com
Medical equipment company to close St. Louis-area plant as it moves work to new $600M facility in NC - The Business Journals
[STE Q1 2027 Earnings Call] STERIS Plans $600M Chemical Manufacturing Hub, Q1 EPS Jumps 11% to $2.59 - finance.biggo.com
Q1 2027 STERIS plc Earnings Call Transcript - GuruFocus
Piper Sandler Maintains Steris PLC(STE.US) With Buy Rating, Cuts Target Price to $270 - Moomoo
Steris Plc (STE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):